Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03399513
Title Ibrutinib and Standard Immuno-Chemotherapy in Younger, High-Risk Patients With Diffuse Large B-Cell Lymphoma (R-CHOEP-brut)
Acronym R-CHOEP-brut
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University Hospital Muenster
Indications
Therapies
Age Groups: adult
Covered Countries DEU


No variant requirements are available.